Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele

To understand gene function, the cre/loxP conditional system is the most powerful available for temporal and spatial control of expression in mouse. However, the research community requires more cre recombinase expressing transgenic mouse strains (cre-drivers) that restrict expression to specific cell types. To address these problems, a high-throughput method for large-scale production that produces high-quality results is necessary. Further, endogenous promoters need to be chosen that drive cell type specific expression, or we need to further focus the expression by manipulating the promoter. Here we test the suitability of using knock-ins at the docking site 5′ of Hprt for rapid development of numerous cre-driver strains focused on expression in adulthood, using an improved cre tamoxifen inducible allele (icre/ERT2), and testing a novel inducible-first, constitutive-ready allele (icre/f3/ERT2/f3). In addition, we test two types of promoters either to capture an endogenous expression pattern (MaxiPromoters), or to restrict expression further using minimal promoter element(s) designed for expression in restricted cell types (MiniPromoters). We provide new cre-driver mouse strains with applicability for brain and eye research. In addition, we demonstrate the feasibility and applicability of using the locus 5′ of Hprt for the rapid generation of substantial numbers of cre-driver strains. We also provide a new inducible-first constitutive-ready allele to further speed cre-driver generation. Finally, all these strains are available to the research community through The Jackson Laboratory.

[1]  E. Simpson,et al.  Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia , 2020, Molecular therapy. Methods & clinical development.

[2]  Rachelle A. Farkas,et al.  New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina , 2019, Human gene therapy.

[3]  S. Thiagalingam,et al.  Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  Eric C. Griffith,et al.  Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing , 2018, Nature Neuroscience.

[5]  Michael Z. Lin,et al.  A Suite of Transgenic Driver and Reporter Mouse Lines with Enhanced Brain-Cell-Type Targeting and Functionality , 2018, Cell.

[6]  Lijia Xiao,et al.  Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription , 2018, Oncogene.

[7]  S. M. Fayaz,et al.  A Novel Five-Node Feed-Forward Loop Unravels miRNA-Gene-TF Regulatory Relationships in Ischemic Stroke , 2018, Molecular Neurobiology.

[8]  J. Cryan,et al.  Regulation of behaviour by the nuclear receptor TLX , 2018, Genes, brain, and behavior.

[9]  Andrea J. Korecki,et al.  Human cis-acting elements regulating escape from X-chromosome inactivation function in mouse , 2018, Human molecular genetics.

[10]  K. Martemyanov,et al.  The Transduction Cascade in Retinal ON-Bipolar Cells: Signal Processing and Disease. , 2017, Annual review of vision science.

[11]  C. Burton,et al.  A review of the role of serotonin system genes in obsessive-compulsive disorder , 2017, Neuroscience & Biobehavioral Reviews.

[12]  C. Elias,et al.  Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model , 2017, Brain Structure and Function.

[13]  P. Gaspar,et al.  RIM1/2 in retinal ganglion cells are required for the refinement of ipsilateral axons and eye-specific segregation , 2017, Scientific Reports.

[14]  V. Gradinaru,et al.  Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems , 2017, Nature Neuroscience.

[15]  Karan H. Patel,et al.  Serotonin receptor 2C regulates neurite growth and is necessary for normal retinal processing of visual information , 2017, Developmental neurobiology.

[16]  K. Kaestner,et al.  High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting , 2017, Molecular metabolism.

[17]  Grace E. Lee,et al.  Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosome , 2016, Scientific Reports.

[18]  M. Bootwalla,et al.  Generation and characterization of tamoxifen‐inducible Pax9‐CreER knock‐in mice using CrispR/Cas9 , 2016, Genesis.

[19]  David J. Arenillas,et al.  PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina , 2016, Molecular therapy. Methods & clinical development.

[20]  Mark W. Moore,et al.  Genome wide conditional mouse knockout resources , 2016 .

[21]  Steven J. M. Jones,et al.  rAAV-compatible MiniPromoters for restricted expression in the brain and eye , 2016, Molecular Brain.

[22]  A. Yoshiki,et al.  Generation of CRISPR/Cas9-mediated bicistronic knock-in ins1-cre driver mice , 2016, Experimental animals.

[23]  M. Nakafuku,et al.  Transgenic expression of the proneural transcription factor Ascl1 in Müller glia stimulates retinal regeneration in young mice , 2015, Proceedings of the National Academy of Sciences.

[24]  B. Rosen,et al.  Beyond knockouts: the International Knockout Mouse Consortium delivers modular and evolving tools for investigating mammalian genes , 2015, Mammalian Genome.

[25]  E. Simpson,et al.  Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. , 2015, Human molecular genetics.

[26]  E. Simpson,et al.  Nr2e1 regulates retinal lamination and the development of Müller glia, S-cones, and glycineric amacrine cells during retinogenesis , 2015, Molecular Brain.

[27]  Carol F. Kirchhoff,et al.  Key considerations in the preclinical development of biosimilars. , 2015, Drug discovery today.

[28]  Anthony G. Robson,et al.  Congenital stationary night blindness: An analysis and update of genotype–phenotype correlations and pathogenic mechanisms , 2015, Progress in Retinal and Eye Research.

[29]  Thomas J. Ha,et al.  Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells , 2015, Science.

[30]  J. Gauldie,et al.  Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes , 2014, Molecular Therapy - Methods & Clinical Development.

[31]  W. Colmers.  Faculty Opinions recommendation of An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. , 2014 .

[32]  N. Uchida,et al.  A Novel Excitatory Paraventricular Nucleus to AgRP Neuron Circuit that Drives Hunger , 2014, Nature.

[33]  Steven J. M. Jones,et al.  Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors , 2014, Molecular therapy. Methods & clinical development.

[34]  K. Kovács.  CRH: The link between hormonal-, metabolic- and behavioral responses to stress , 2013, Journal of Chemical Neuroanatomy.

[35]  T. Hensch,et al.  Germline recombination by conditional gene targeting with Parvalbumin-Cre lines , 2013, Front. Neural Circuits.

[36]  Steven J. M. Jones,et al.  Non-coding-regulatory regions of human brain genes delineated by bacterial artificial chromosome knock-in mice , 2013, BMC Biology.

[37]  J. Pachter,et al.  Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. , 2013, Microvascular research.

[38]  Hunter B. Fraser,et al.  Differences in enhancer activity in mouse and zebrafish reporter assays are often associated with changes in gene expression , 2012, BMC Genomics.

[39]  Steve D. M. Brown,et al.  The mammalian gene function resource: the international knockout mouse consortium , 2012, Mammalian Genome.

[40]  J. Eppig,et al.  Beyond knockouts: cre resources for conditional mutagenesis , 2012, Mammalian Genome.

[41]  E. Simpson,et al.  Modelling Human Regulatory Variation in Mouse: Finding the Function in Genome-Wide Association Studies and Whole-Genome Sequencing , 2012, PLoS genetics.

[42]  L. Fañanás,et al.  The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety‐related traits , 2012, Acta psychiatrica Scandinavica.

[43]  E. Simpson,et al.  Retina Restored and Brain Abnormalities Ameliorated by Single-Copy Knock-In of Human NR2E1 in Null Mice , 2012, Molecular and Cellular Biology.

[44]  F. Holsboer,et al.  Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1 , 2011, Science.

[45]  S. Nelson,et al.  A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex , 2011, Neuron.

[46]  D. Rubinow,et al.  Elevated corticotropin releasing hormone (CRH) during pregnancy and risk of postpartum depression (PPD). , 2010, The Journal of clinical endocrinology and metabolism.

[47]  Steven J. M. Jones,et al.  A regulatory toolbox of MiniPromoters to drive selective expression in the brain , 2010, Proceedings of the National Academy of Sciences.

[48]  Eloísa Herrera,et al.  Zic2 regulates the expression of Sert to modulate eye-specific refinement at the visual targets , 2010, The EMBO journal.

[49]  Norio Nakatsuji,et al.  Efficient integration of transgenes into a defined locus in human embryonic stem cells , 2010, Nucleic acids research.

[50]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[51]  Frank Buchholz,et al.  Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice , 2009, Disease Models & Mechanisms.

[52]  M. Olson,et al.  Tissue selective expression of conditionally‐regulated ROCK by gene targeting to a defined locus , 2009, Genesis.

[53]  F. Jaisser,et al.  Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system. , 2009, Physiological genomics.

[54]  P. Opolon,et al.  Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS , 2009, Gene Therapy.

[55]  E. Simpson,et al.  Next generation tools for high-throughput promoter and expression analysis employing single-copy knock-ins at the Hprt1 locus. , 2009, Genomics.

[56]  P. Nurden,et al.  Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1 , 2008, Thrombosis and Haemostasis.

[57]  Paul S. Horn,et al.  Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder , 2008, Psychoneuroendocrinology.

[58]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[59]  G. Schütz,et al.  Inducible gene inactivation in neurons of the adult mouse forebrain , 2007, BMC Neuroscience.

[60]  A. Bhandoola,et al.  Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.

[61]  C. S. Raymond,et al.  High-Efficiency FLP and ΦC31 Site-Specific Recombination in Mammalian Cells , 2007, PloS one.

[62]  E. Simpson,et al.  Deletion of the nuclear receptor Nr2e1 impairs synaptic plasticity and dendritic structure in the mouse dentate gyrus , 2006, Neuroscience.

[63]  Inna Dubchak,et al.  VISTA Enhancer Browser—a database of tissue-specific human enhancers , 2006, Nucleic Acids Res..

[64]  D. Siderovski,et al.  G-protein alpha subunit interaction and guanine nucleotide dissociation inhibitor activity of the dual GoLoco motif protein PCP-2 (Purkinje cell protein-2). , 2006, Cellular signalling.

[65]  B. Abrahams,et al.  Pathological Aggression in “Fierce” Mice Corrected by Human Nuclear Receptor 2E1 , 2005, The Journal of Neuroscience.

[66]  B. Gong,et al.  Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice. , 2005, Journal of molecular and cellular cardiology.

[67]  Akiyoshi Uemura,et al.  Tlx, an Orphan Nuclear Receptor, Regulates Cell Numbers and Astrocyte Development in the Developing Retina , 2004, The Journal of Neuroscience.

[68]  J. Heaney,et al.  Tissue-specific expression of a BAC transgene targeted to the Hprt locus in mouse embryonic stem cells. , 2004, Genomics.

[69]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[70]  K. Campbell,et al.  Tlx Controls Proliferation and Patterning of Lateral Telencephalic Progenitor Domains , 2003, The Journal of Neuroscience.

[71]  T. Hudson,et al.  A Combinatorial Network of Evolutionarily Conserved Myelin Basic Protein Regulatory Sequences Confers Distinct Glial-Specific Phenotypes , 2003, The Journal of Neuroscience.

[72]  A. McMahon,et al.  Maternal inheritance of Cre activity in a Sox2Cre deleter strain , 2003, Genesis.

[73]  S. J. McCoy,et al.  Endocrine factors and postpartum depression. A selected review. , 2003, The Journal of reproductive medicine.

[74]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[75]  J. Oberdick,et al.  Conservation of the developmentally regulated dendritic localization of a Purkinje cell-specific mRNA that encodes a G-protein modulator: comparison of rodent and human Pcp2(L7) gene structure and expression. , 2002, Brain research. Molecular brain research.

[76]  C. Mahaffey,et al.  Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent , 2002, Behavioural Brain Research.

[77]  P. Seeburg,et al.  Codon‐improved Cre recombinase (iCre) expression in the mouse , 2002, Genesis.

[78]  H. Wässle,et al.  Morphological and physiological properties of the A17 amacrine cell of the rat retina , 2000, Visual Neuroscience.

[79]  D. Court,et al.  An efficient recombination system for chromosome engineering in Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. Gábriel.  Calretinin is present in serotonin- and γ-aminobutyric acid-positive amacrine cell populations in the retina of Xenopus laevis , 2000, Neuroscience Letters.

[81]  P Chambon,et al.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. , 1999, Nucleic acids research.

[82]  D. Metzger,et al.  Engineering the mouse genome by site-specific recombination. , 1999, Current opinion in biotechnology.

[83]  P. Gaspar,et al.  Excess of Serotonin (5-HT) Alters the Segregation of Ispilateral and Contralateral Retinal Projections in Monoamine Oxidase A Knock-Out Mice: Possible Role of 5-HT Uptake in Retinal Ganglion Cells During Development , 1999, The Journal of Neuroscience.

[84]  P. Gaspar,et al.  Transient developmental expression of monoamine transporters in the rodent forebrain , 1998 .

[85]  David J. Anderson,et al.  Fate mapping of the mouse midbrain–hindbrain constriction using a site-specific recombination system , 1998, Current Biology.

[86]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[87]  R. Kucherlapati,et al.  Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. , 1997, Genomics.

[88]  N. Maeda,et al.  Single-copy transgenic mice with chosen-site integration. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[89]  T. Schlake,et al.  Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. , 1994, Biochemistry.

[90]  J. Herman,et al.  Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. , 1994, Endocrinology.

[91]  J. Grice,et al.  Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder , 1993, Biological Psychiatry.

[92]  J. Mitchell,et al.  Activity of yeast FLP recombinase in maize and rice protoplasts. , 1993, Nucleic acids research.

[93]  H. Orr,et al.  Purkinje cell protein-2 regulatory regions and transgene expression in cerebellar compartments. , 1991, Genes & development.

[94]  H. Wässle,et al.  Dopaminergic and indoleamine-accumulating amacrine cells express GABA- like immunoreactivity in the cat retina , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[95]  N. Osborne,et al.  Direct histochemical localisation of 5,7-dihydroxytryptamine and the uptake of serotonin by a subpopulation of GABA neurones in the rabbit retina , 1986, Brain Research.

[96]  R. Hoess,et al.  The role of the loxP spacer region in P1 site-specific recombination. , 1986, Nucleic acids research.

[97]  A. Schally,et al.  Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. , 1982, The American journal of anatomy.

[98]  D. Farmakis,et al.  Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications , 2017, Heart Failure Reviews.

[99]  Olivier Marre,et al.  Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[100]  M. Macek,et al.  The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature. , 2010, Neuro endocrinology letters.

[101]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[102]  P. Gaspar,et al.  Transient developmental expression of monoamine transporters in the rodent forebrain. , 1998, The Journal of comparative neurology.